| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 合富（中国）医疗科技股份有限公司是一个以创新为本的企业。 在业务模式创新上，合富2008年于全国率先推出为医院提供体外诊断试剂集采服务，至今已完整建立了与国内外各大检验设备试剂原厂直接合作销货给终端客户的供应链关系； 在创新科技医疗设备的业务发展上，合富成功引进市场的立体定位肿瘤放疗设备及干眼症检查和治疗设备当时都属全球领先，这也奠定了合富在国内外业界的创新科技产品进入市场的成功营销伙伴地位。 合富成立以来就搭建了优质的两岸医疗交流合作平台，二十几载间已为大陆医院发展引荐了台湾的医院管理人才和制度，创造了两岸医疗交流和临床科室合作，还培育了数以千计的医护人才，赢得了众多客户的高度信赖认可。 “合富”这个简洁明了的名字，概括了我们企业的经营理念“合作致富”。合富的创立是为了达成协助提升大中华医疗水准的使命，期盼所有的医院能够拥有世界一流的医疗设备，令绝大部分人群可以享受到世界先进的医疗技术。 合富的各项领域都能够提升医院经济效益，包括节省成本、创造新项目的收益等；同时也为医院带来包括医疗技术的进步、医院服务效率的提升、学术活动的支持等社会效益。 合富不仅目前与七十多家世界级医疗制造商直接建立策略联盟，更积极地垂直整合医疗领域高新科技优质供应商，以多种模式与其合作；同时水平整合同业间的各类资源，深度扩展并紧密合作。如此多元化的发展将使得合富与医院的合作领域不断扩大。 我们所有的业务模式都是本着长期双赢的经营理念。合富与医院的合作大部分都签订5—8年的长期合约，并在合作期间，合富竭尽全力地向客户展示“长期双赢”的真正意义。一个接着一个源源不断的成功案例，使得客户对我们的信赖不断加强，所以合富由1997年获得第1个客户的认同，到如今已经拥有了超过500个客户； | ||||||||||||||||||||||||
| Main Business | 系医疗流通领域的渠道商，具备与境内外试剂耗材和医疗设备原厂、各大代理商及医疗机构长期互惠、合作共赢的核心竞争力。 | ||||||||||||||||||||||||
| Legal Representative | 王琼芝 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 陈烨 | ||||||||||||||||||||||||
| Solicitors | 上海市方达律师事务所 | ||||||||||||||||||||||||
| Auditors | 毕马威华振会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 021-60378999 | ||||||||||||||||||||||||
| Fax No | 021-60378951 | ||||||||||||||||||||||||
| Website | www.cowealth.com | ||||||||||||||||||||||||
| ir_cowealth@cowealth.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 16/02/2022 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.120 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.060 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.931 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.385B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |